@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:lead . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T19:48:05.721783"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "to lower risk of mortality with an odds ratio ( OR ) of 0.85 ( 95 % CrI" . rdf:OBJECT-POSITION rdfs:label "16"^^xsd:integer . rdf:PREDICATE rdfs:label "led" . rdf:PREDICATE-POSITION rdfs:label "[105]" . rdf:SUBJECT rdfs:label "dexamethasone" . rdf:SUBJECT-POSITION rdfs:label "91"^^xsd:integer . rdfs:ABSTRACT-UID ns2:50 "bls5qllx" . rdfs:SENTENCE rdfs:label "Compared with the standard of care (SOC), Bayesian network meta-analysis (NMA) showed that dexamethasone led to lower risk of mortality with an odds ratio (OR) of 0.85 (95% CrI [0.76, 0.95]; moderate certainty) and lower risk of mechanical ventilation (MV) with an OR of 0.68 (95% CrI [0.56, 0.83]; low certainty)." . rdfs:TRIPLE-UID ns3:bls5qllx-TRIPLE-ABSTRACT-3 "bls5qllx-TRIPLE-ABSTRACT-3" . rdfs:label "dexamethasone" . rdfs:label "mortality" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "ToJLJgqcvg+N0zxZtSMrD0lfOjvWpFofNt5PnbOoJlytiKG5TuxJayorKQbbklwVI+oh1REhM2tyiqWbnmr6N1GpSWGWRz6kSM/TSjAjIuCfViYPckHKVY0uYp93I0QYELwJeArP2LstbjdrEvLskdi0jr6ffzsVdGarhBDJXU8="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T19:48:05.721783"^^xsd:dateTime; prov:wasAttributedTo . }